Interleukin-4 in patients with prostate cancer

Anticancer Research

Volumn 25, Issue 6 C, 2005, Pages 4595-4598

  Ueda, Takeshi ^a,d   Sadar, Marianne D ^b   Suzuki, Hiroyoshi ^a   Akakura, Koichiro ^c   Sakamoto, Shinichi ^a   Shimbo, Masaki ^a   Suyama, Takahito ^a   Imamoto, Takashi ^a   Komiya, Akira ^a   Yukio, Naya ^a   Ichikawa, Tomohiko ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

^c TOKYO KOSEI NENKIN HOSPITAL   (Japan)

^d CHIBA CANCER CENTER   (Japan)

Author keywords

Androgen receptor; Interleukin 4; Interleukin 6; Prostate cancer

Indexed keywords

ANDROGEN RECEPTOR; ANTIANDROGEN; INTERLEUKIN 4; INTERLEUKIN 6; LIGAND; LUCIFERASE; METRIBOLONE; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; AMINO TERMINAL SEQUENCE; ANDROGEN RESPONSE ELEMENT; ARTICLE; BLOOD LEVEL; CANCER GROWTH; CHEMOLUMINESCENCE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; GENE ACTIVITY; GENETIC TRANSFECTION; HORMONE RESPONSIVE ELEMENT; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROTEIN DOMAIN; RECEPTOR UPREGULATION; REPORTER GENE; RETROSPECTIVE STUDY; TRANSACTIVATION;

ADULT; AGED; CELL LINE, TUMOR; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERLEUKIN-4; MALE; METRIBOLONE; NEOPLASMS, HORMONE-DEPENDENT; PROMOTER REGIONS (GENETICS); PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; TRANSFECTION;

EID: 28444450417     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Nelms K, Keegan AD, Zamorano J, Ryan JJ and Paul WE: The IL-4 receptor: signaling mechanisms and biologic functions. Annu Rev Immunol 17: 701-738, 1999.
2. Smerz-Bertling C and Duschl A: Both interleukin 4 and interleukin 13 induce tyrosine phosphorylation of the 140-kDa subunit of the interleukin 4 receptor. J Biol Chem 270: 966-970, 1995.
3. Johnston JA, Kawamura M, Kirken RA, Chen YQ, Blake TB, Shibuya K, Ortaldo JR, McVicar DW and O'Shea JJ: Phosphorylation and activation of the Jak-3 Janus kinase in response to interleukin-2. Nature 370: 151-153, 1994.
4. Wang LM, Myers MG Jr, Sun XJ, Aaronson SA, White M and Pierce JH: IRS-1: essential for insulin- and IL-4-stimulated mitogenesis in hematopoietic cells. Science 267: 1591-1594, 1993.
5. Zhou MM, Huang B, Olejniczak ET, Meadows RP, Shuker SB, Miyazaki M, Trub T, Shoelson SE and Fesik SW: Structural basis for IL-4 receptor phosphopeptide recognition by the IRS-1 PTB domain. Nat Struct Biol 3: 388-393, 1996.
6. Shimoda K, van Deursen J, Sangster MY, Sarawar SR, Carson RT, Tripp RA, Chu C, Quelle FW, Nosaka T, Vignali DA, Doherty PC, Grosveld G, Paul WE and Ihle JN: Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature 380: 630-633, 1996.
7. Wise GJ, Marella VK, Talluri G and Shirazian D: Cytokine variations in patients with hormone treated prostate cancer. J Urol 164: 722-725, 2000.
8. Sadar MD: Androgen-independent induction of prostate-specific antigen gene expression via cross-talk between the androgen receptor and protein kinase A signal transduction pathways. J Biol Chem 274: 7777-7783, 1999.
9. Ueda T, Bruchovsky N and Sadar MD: Activation of the androgen receptor N-terminal domain by interleukin-6 via MAPK and STAT3 signal transduction pathways. J Biol Chem 277: 7076-7085, 2002.
10. Ueda T, Mawji NR, Bruchovsky N and Sadar MD: Ligand-independent activation of the androgen receptor by interleukin-6 and the role of steroid receptor coactivator-1 in prostate cancer cells. J Biol Chem 277: 38087-38094, 2002.
11. Blaszczyk N, Masri BA, Mawji NR, Ueda T, McAlinden G, Duncan CP, Bruchovsky N, Schweikert HU, Schnabel D, Jones EC and Sadar MD: Osteoblast-derived factors induce androgen-independent proliferation and expression of prostate-specific antigen in human prostate cancer cells. Clin Cancer Res 10: 1860-1869, 2004.
12. Culig Z, Hobisch A, Cronauer MV, Radmayr C, Trapman J, Hittmair A, Bartsch G and Klocker H: Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor. Cancer Res 54: 5474-5478, 1994.
13. Sadar MD, Hussain M and Bruchovsky N: Prostate cancer: molecular biology of early progression to androgen independence. Endocr Relat Cancer 6: 487-502, 1999.
14. Lee SO, Lou W, Hou M, Onate SA and Gao AC: Interleukin-4 enhances prostate-specific antigen expression by activation of the androgen receptor and Akt pathway. Oncogene 22: 7981-7988, 2003.